Company intelligence / Profile preview

COI Pharmaceuticals

La Jolla, California, United Statesavalon-ventures.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

COI Pharmaceuticals provides infrastructure and operational support to Avalon Ventures’ life science portfolio companies. It has enabled the launch and advancement of multiple biotech startups targeting areas such as celiac disease (Sitari Pharmaceuticals), iron overload disorders (Silarus Therapeutics), and immuno-oncology (PDI Therapeutics). These startups have achieved key preclinical milestones under its guidance but clinical results are reported at the subsidiary level rather than by COI itself.

Therapeutic areas: GastroenterologyOncologyHematology
Modalities: Small moleculeBiologic
Industry: Investors

Partnerships

GlaxoSmithKline (GSK) – collaboration to co-found new biotechs with Avalon Ventures through the COI platform

Beyond the preview

Go deeper on COI Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COI Pharmaceuticals.

Explore the full profile